Année 2011

Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J, Cabaret O, Canonico M, Verstuyft C, Dubert L, Becquemont L, Guiochon-Mantel A, Scarabin PY.
Clin Pharmacol Ther. 2011 Jan;89(1):60-4.

Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.
Caprio M, Antelmi A, Chetrite G, Muscat A, Mammi C, Marzolla V, Fabbri A, Zennaro MC, Fève B.
Endocrinology. 2011 Jan;152(1):113-25.

Mineralocorticoid Receptor Mutations Differentially Affect Individual Gene Expression Profiles in Pseudohypoaldosteronism Type 1.
Fernandes-Rosa FL, Hubert EL, Fagart J, Tchitchek N, Gomes D, Jouanno E, Benecke A, Rafestin-Oblin ME, Jeunemaitre X, Antonini SR, Zennaro MC.
J Clin Endocrinol Metab. 2011 Mar;96(3):E519-27.

Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.
Devi YS, Seibold A, Shehu A, Maizels E, Helparin J, Le J, Binart N, Bao L, Gibori G.
J Biol Chem. 2011 Mar 4;286(9):7609-18

Modulation of Brain -Endorphin Concentration by the Specific Part of the Y Chromosome in Mice.
Botbol M, Roubertoux PL, Carlier M, Trabado S, Brailly-Tabard S, Perez-Diaz F, Bonnot O, Bronsard G, Tordjman S.
PLoS One. 2011 Mar 8;6(3):e16704.

Ligand-Dependent Degradation of SRC-1 Is Pivotal for Progesterone Receptor Transcriptional Activity.
Amazit L, Roseau A, Khan JA, Chauchereau A, Tyagi RK, Loosfelt H, Leclerc P, Lombès M, Guiochon-Mantel A.
Mol Endocrinol. 2011 Mar;25(3):394-408.

Place of Cabergoline in Acromegaly: A Meta-Analysis.
Sandret L, Maison P, Chanson P.
J Clin Endocrinol Metab. 2011 May;96(5):1327-35.

Aldosterone Postnatally, but not at Birth, Is Required for Optimal Induction of Renal Mineralocorticoid Receptor Expression and Sodium Reabsorption.
Martinerie L, Viengchareun S, Meduri G, Kim HS, Luther JM, Lombès M.
Endocrinology. 2011 Jun;152(6):2483-91.

Body Fluid Expansion in Acromegaly Is Related to Enhanced Epithelial Sodium Channel (ENaC) Activity.
Kamenicky P, Blanchard A, Frank M, Salenave S, Letierce A, Azizi M, Lombès M, Chanson P.
J Clin Endocrinol Metab. 2011 Jul;96(7):2127-35.

Ce travail a été sélectionné et évalué par un membre du « Faculty of 1000″, qui a classé cet article dans le Top 2% des articles publiés en biologie et en médecine

 

Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
Trabado S, Maione L, Salenave S, Baron S, Galland F, Bry-Gauillard H, Guiochon-Mantel A, Chanson P, Pitteloud N, Sinisi AA, Brailly-Tabard S, Young J.
Fertil Steril. 2011 Jun;95(7):2324-2329

Prevalence and Incidence of Diabetes Mellitus in Adult Patients on Growth Hormone Replacement for Growth Hormone Deficiency: a Surveillance Database Analysis.
Attanasio AF, Jung H, Mo D, Chanson P, Bouillon R, Ho KK, Lamberts SW, Clemmons DR; for the HypoCCS International Advisory Board.
J Clin Endocrinol Metab. 2011 Jul;96(7):2255-2261.

Integrated genomic profiling identifies loss of chromosome 11p impacting transcriptomic activity in aggressive pituitary PRL tumours.
Wierinckx A, Roche M, Raverot G, Legras-Lachuer C, Croze S, Nazaret N, Rey C, Auger C, Jouanneau E, Chanson P, Trouillas J, Lachuer J.
Brain Pathol. 2011 Sep;21(5):533-543.

Differential Recruitment of MBDs and Dnmts by the Orphan Receptor GCNF Initiates the Repression and Silencing of Oct4.
Gu P, Xu X, Le Menuet D, Chung AC, Cooney AJ.
Stem Cells. 2011 Jul;29(7):1041-51.

Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer.
Brassard M, Neraud B, Trabado S, Salenave S, Brailly-Tabard S, Borget I, Baudin E, Leboulleux S, Chanson P, Schlumberger M, Young J.
J Clin Endocrinol Metab. 2011 Sep;96(9):2741-9.

Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing’s Syndrome.
Kamenicky P, Droumaguet C, Salenave S, Blanchard A, Jublanc C, Gautier JF, Brailly-Tabard S, Leboulleux S, Schlumberger M, Baudin E, Chanson P, Young J.
J Clin Endocrinol Metab. 2011 Sep;96(9):2796-804.

Vasopressin, ATP and catecholamines differentially control potassium secretion in inner ear cell line.
Nevoux J, Teixeira M, Viengchareun S, Cosson C, Butlen D, Lombes M, Ferrary E.
FEBS Lett. 2011 Sep 2;585(17):2703-8.

Transcriptional control of adrenal steroidogenesis : novel connection between JAK2 and PKA through stabilization of transcription factor CREB.
Lefrancois-Martinez AM, Blondet-Trichard A, Binart N, Val P, Chambon C, Sahut-Barnola I, Pointud JC, Martinez A.
J Biol Chem. 2011 Sep 23;286(38):32976-85.

Pelvic MRI in a 17-year-old XY girl with 5-alpha reductase deficiency and a homozygous Gly115Asp mutation in SRD5A2.
Sarfati J, Trabado S, Rocher L, Mallet D, Betari-Tabet B, Morel Y, Young J.
Ann Endocrinol (Paris). 2011 Sep;72(4):310-3.

The European Registry on Cushing’s syndrome: 2-year experience. Baseline demographic and clinical characteristics.
Valassi E, Santos A, Yaneva M, Tóth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM; The ERCUSYN Study Group.
Eur J Endocrinol. 2011 Sep;165(3):383-392

Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations.
Francou B, Bouligand J, Voican A, Amazit L, Trabado S, Fagart J, Meduri G, Brailly-Tabard S, Chanson P, Lecomte P, Guiochon-Mantel A, Young J.
PLoS One. 2011;6(10):e25614.

Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort.

Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N.
Hum Mutat. 2011 Oct;32(10):1108-13.

Thyroid-stimulating hormone, 5-HTTLPR genotype, and antidepressant response in depressed women.
Gressier F, Trabado S, Verstuyft C, Bouaziz E, Hardy P, Fève B, Becquemont L, Corruble E.
Psychiatr Genet. 2011 Oct;21(5):253-6.

p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization.
Khan JA, Amazit L, Bellance C, Guiochon-Mantel A, Lombès M, Loosfelt H.
Mol Endocrinol. 2011 Oct;25(10):1710-24.

Treatment of neurogenic diabetes insipidus.
Chanson P, Salenave S.
Ann Endocrinol (Paris). 2011 Dec;72(6):496-9.

[Cryopreserved ovaries: models of experimental grafting].
Binart N, Sauvat F.
Biol Aujourdhui. 2011;205(4):235-43.